Retinopathy predicts coronary heart disease events in NIDDM patients

Diabetes Care

Volumn 19, Issue 12, 1996, Pages 1445-1448

  Miettinen, Heikki ^a,d,e   Haffner, Steven M ^d   Lehto, Seppo ^a   Rönnemaa, Tapani ^b,c   Pyörälä, Kalevi ^a   Laakso, Markku ^a,f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREDICTION; RISK ASSESSMENT;

EID: 0029912704     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.12.1445     Document Type: Article

References (15)

1. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
2. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:962-967, 1994
3. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988
4. Klein R, Moss SE, Klein BEK, DeMets DL: Relation of ocular and systemic factors to survival. Arch Intern Med 149:266-272, 1989
5. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I: Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 11:449-463, 1988
6. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K: Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia 38:487-493, 1995
7. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpää J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, Puska P, Pyörälä K, Salomaa V, Torppa J, Vuorenmaa T: Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J 13:577-587, 1992
8. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219-226, 1989
9. Klein R, Klein BEK, Moss SE: Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15:1875-1891, 1992
10. Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, van Heuven WAJ, Klein R: Diabetic retinopathy in Mexican Americans and Non-Hispanic Whites. Diabetes 37:878-884, 1988
11. Knowler WC, Bennett PH, Ballintine EJ: Increased incidence of retinopathy in diabetics with elevated blood pressure: a six-year follow-up study in Pima Indians. N Engl J Med 302:645-650, 1980
12. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
13. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
14. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H: Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44:1303-1309, 1995
15. Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria: implications for micro- and macrovascular disease. Diabetes Care 15:1181-1191, 1992